Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma

BackgroundOver the past decade, the remarkable rise in differentiated thyroid carcinoma (DTC) incidence, combined with the limitations of conventional diagnostic approaches, have prompted this study to explore the diagnostic value of thyroid-related serological indicators and pan-immune-inflammation...

Full description

Saved in:
Bibliographic Details
Main Authors: Yicheng Wen, Xin Yi, Jixin Shi, Peng Wan, Huan Wang, Li Tian, Huixia Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1662638/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233662740004864
author Yicheng Wen
Xin Yi
Jixin Shi
Peng Wan
Huan Wang
Li Tian
Huixia Liu
author_facet Yicheng Wen
Xin Yi
Jixin Shi
Peng Wan
Huan Wang
Li Tian
Huixia Liu
author_sort Yicheng Wen
collection DOAJ
description BackgroundOver the past decade, the remarkable rise in differentiated thyroid carcinoma (DTC) incidence, combined with the limitations of conventional diagnostic approaches, have prompted this study to explore the diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value (PIV) for DTC, based on advancements in molecular biology and immunology.MethodsBased on postoperative pathological diagnosis, the present retrospective research comprised 112 individuals afflicted with DTC (observation group) and 93 individuals having benign thyroid tumors (control group) from January 2023 to January 2025. Differences in clinical data between the two groups were analyzed via univariate statistical methods. Logistic regression analyses identified influencing factors, while diagnostic value of thyroid-related serological indicators and PIV levels were evaluated through receiver operating characteristic analysis.ResultsIntergroup differences regarding the levels of thyroxine (T4), free thyroxine (FT4), thyroid-stimulating hormone (TSH), thyroglobulin (Tg), lymphocyte count, monocyte count, and PIV were found to be significant (p<0.05). Additionally, negative correlation of lymphocyte count with DTC was noted by univariate binary logistic regression (odds ratio [OR] = 0.243, 95% confidence interval [CI]: 0.143–0.411]). TSH (OR=2.458, 95% CI: 1.690–3.575), FT4 (OR=1.383, 95% CI: 1.205–1.588), Tg (OR=1.008, 95% CI: 1.001–1.015), and PIV (OR=1.003, 95% CI: 1.000–1.005) were identified as independent influencing factors for DTC, and the area under the curve for their combination was 0.860 (95% CI: 0.809–0.912, sensitivity: 86.2%, specificity: 77.2%).ConclusionThis retrospective study suggested that TSH, FT4, Tg, and PIV were positively correlated with DTC, and their combination yielded the best diagnostic performance. It highlighted the potential utility of PIV as a novel immune-inflammatory biomarker and provided support for the development of DTC diagnosis.
format Article
id doaj-art-195506f02555494ea9e2957d7dd45f74
institution Kabale University
issn 1664-3224
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-195506f02555494ea9e2957d7dd45f742025-08-20T04:14:19ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-08-011610.3389/fimmu.2025.16626381662638Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinomaYicheng Wen0Xin Yi1Jixin Shi2Peng Wan3Huan Wang4Li Tian5Huixia Liu6School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Medicine, Tarim University, Alaer, ChinaBackgroundOver the past decade, the remarkable rise in differentiated thyroid carcinoma (DTC) incidence, combined with the limitations of conventional diagnostic approaches, have prompted this study to explore the diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value (PIV) for DTC, based on advancements in molecular biology and immunology.MethodsBased on postoperative pathological diagnosis, the present retrospective research comprised 112 individuals afflicted with DTC (observation group) and 93 individuals having benign thyroid tumors (control group) from January 2023 to January 2025. Differences in clinical data between the two groups were analyzed via univariate statistical methods. Logistic regression analyses identified influencing factors, while diagnostic value of thyroid-related serological indicators and PIV levels were evaluated through receiver operating characteristic analysis.ResultsIntergroup differences regarding the levels of thyroxine (T4), free thyroxine (FT4), thyroid-stimulating hormone (TSH), thyroglobulin (Tg), lymphocyte count, monocyte count, and PIV were found to be significant (p<0.05). Additionally, negative correlation of lymphocyte count with DTC was noted by univariate binary logistic regression (odds ratio [OR] = 0.243, 95% confidence interval [CI]: 0.143–0.411]). TSH (OR=2.458, 95% CI: 1.690–3.575), FT4 (OR=1.383, 95% CI: 1.205–1.588), Tg (OR=1.008, 95% CI: 1.001–1.015), and PIV (OR=1.003, 95% CI: 1.000–1.005) were identified as independent influencing factors for DTC, and the area under the curve for their combination was 0.860 (95% CI: 0.809–0.912, sensitivity: 86.2%, specificity: 77.2%).ConclusionThis retrospective study suggested that TSH, FT4, Tg, and PIV were positively correlated with DTC, and their combination yielded the best diagnostic performance. It highlighted the potential utility of PIV as a novel immune-inflammatory biomarker and provided support for the development of DTC diagnosis.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1662638/fullimmune-inflammatory biomarkerspan-immune-inflammation valuediagnostic valuethyroid-related serological indicatorsdifferentiated thyroid carcinoma
spellingShingle Yicheng Wen
Xin Yi
Jixin Shi
Peng Wan
Huan Wang
Li Tian
Huixia Liu
Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
Frontiers in Immunology
immune-inflammatory biomarkers
pan-immune-inflammation value
diagnostic value
thyroid-related serological indicators
differentiated thyroid carcinoma
title Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
title_full Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
title_fullStr Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
title_full_unstemmed Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
title_short Diagnostic value of thyroid-related serological indicators and pan-immune-inflammation value for differentiated thyroid carcinoma
title_sort diagnostic value of thyroid related serological indicators and pan immune inflammation value for differentiated thyroid carcinoma
topic immune-inflammatory biomarkers
pan-immune-inflammation value
diagnostic value
thyroid-related serological indicators
differentiated thyroid carcinoma
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1662638/full
work_keys_str_mv AT yichengwen diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT xinyi diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT jixinshi diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT pengwan diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT huanwang diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT litian diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma
AT huixialiu diagnosticvalueofthyroidrelatedserologicalindicatorsandpanimmuneinflammationvaluefordifferentiatedthyroidcarcinoma